RAC 2.92% $1.94 race oncology ltd

Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing, page-68

  1. 2,653 Posts.
    lightbulb Created with Sketch. 2395
    Is the "patent protection to 2044" comment in the release a deliberate notice informing us that the application goes in this year?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.